China has such a dominant position in active pharmaceutical ingredient (API) production that there is a risk it could "weaponise" access, according to a new congressional report. The document, from ...
Phishing surge, LinkedIn tracking claims, spyware use, and rising stealers expose growing abuse of trusted systems.